ARCHIVES

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 11 | November 25, 2005

Download PDF Visit The Full Archive

Related Articles

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

GA Draft Report Lukewarm On Cancer Survival Improvement; NCI Says It Is “Opinion, Not Fact”

April 3, 1987

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

FOCR Report Offers Recommendations, Definitions for CER

May 22, 2009